ESPR vs ILMN · rev $332.3M vs rev $4.34B
Esperion Therapeutics Inc (ESPR) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
ESPR currently screens at market cap $816.9M. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the ESPR and ILMN stock pages for the full models.
Not investment advice.